INTEGRA LIFESCIENCES HOLDINGS CORPORATION

Integra LifeSciences Holdings Corporation

Equities

IART

US4579852082

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 01:30:00 18/05/2024 am IST			5-day change	1st Jan Change
27.54 ^USD	+0.18%		+5.96%	-36.76%

17/05	Sector Update: Health Care Stocks Steady Pre-Bell Friday	MT
17/05	Integra LifeSciences Holdings to Repurchase $50 Million in Shares	MT

Integra LifeSciences : Asian American & Pacific Islander (AAPI) Heritage Month – Advancing Leaders Through Innovation

May 06, 2024 at 11:29 pm IST

Jennifer Costales, product manager in Canada for Tissue Technologies (TT) is leading the way to support the development of Asian talent at Integra. [...]

This is an abstract of the document. To keep reading, click here and get access to the original version.

Attachments

Original Link
Permalink

Disclaimer

Integra LifeSciences Holdings Corporation published this content on 06 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 May 2024 17:58:10 UTC.

Latest news about Integra LifeSciences Holdings Corporation

Sector Update: Health Care Stocks Steady Pre-Bell Friday	17/05	MT
Integra LifeSciences Holdings to Repurchase $50 Million in Shares	17/05	MT
Transcript : Integra LifeSciences Holdings Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 01:40 PM	15/05
Truist Cuts Price Target on Integra LifeSciences Holdings to $25 From $37, Keeps Hold Rating	07/05	MT
Wells Fargo Downgrades Integra LifeSciences Holdings to Equalweight From Overweight, Cuts Price Target to $25 From $45	07/05	MT
Oppenheimer Downgrades Integra LifeSciences Holdings to Perform From Outperform	07/05	MT
Integra LifeSciences Shares Drop to Record Low on Unexpected Loss, Boston Facility Audit Findings	06/05	DJ
Transcript : Integra LifeSciences Holdings Corporation, Q1 2024 Earnings Call, May 06, 2024	06/05
Integra LifeSciences Q1 Adjusted Earnings, Revenue Fall; Updates 2024 Outlook	06/05	MT
North American Morning Briefing : Stock Futures -2-	06/05	DJ
Integra LifeSciences Holdings Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	06/05	CI
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Reports Q1 Revenue $368.9M, vs. Street Est of $362M	06/05	MT
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Posts Q1 EPS $0.55, vs. Street Est of $0.55	06/05	MT
Integra LifeSciences Holdings Corporation Provides Revenue Guidance for the Second Quarter of 2024	06/05	CI
North American Morning Briefing : Focus Turns to -2-	04/04	DJ
Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target	03/04	MT
Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Price Target is $38	03/04	MT
Integra LifeSciences Completes Acquisition of Acclarent	02/04	MT
Integra LifeSciences Holdings Corporation acquired 100% stake in Acclarent, Inc. from Ethicon US, LLC for $280 million.	01/04	CI
Integra Lifesciences Launches Micromatrix Flex to Provide Convenient Access to Hard-To-Reach Areas in Complex Cases	11/03	CI
Integra Lifesciences Holdings Insider Sold Shares Worth $305,492, According to a Recent SEC Filing	09/03	MT
Truist Securities Cuts Price Target on Integra LifeSciences Holdings to $41 From $46, Maintains Hold Rating	01/03	MT
Tranche Update on Integra LifeSciences Holdings Corporation's Equity Buyback Plan announced on July 27, 2023.	29/02	CI
Integra LifeSciences Shares Drop Following Q4 Results	28/02	MT
Integra LifeSciences Seeks Acquisitions	28/02	CI

Chart Integra LifeSciences Holdings Corporation

Duration

Period

Chart Integra LifeSciences Holdings Corporation

More charts

Company Profile

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

24/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Integra LifeSciences Holdings Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

27.54 USD

Average target price

33.8 USD

Spread / Average Target

+22.73%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
INTEGRA LIFESCIENCES HOLDINGS CORPORATION	-36.76%	2.17B
ABBOTT LABORATORIES	-5.43%	181B
MEDTRONIC PLC	+4.30%	114B
BECTON, DICKINSON AND COMPANY	-3.09%	68.29B
DEXCOM, INC.	+5.86%	52.24B
CENCORA, INC.	+8.15%	44.3B
HOYA CORPORATION	+7.52%	42.73B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.54%	32.52B
TERUMO CORPORATION	+17.85%	26.02B
WEST PHARMACEUTICAL SERVICES, INC.	+1.00%	25.91B

Other Medical Equipment, Supplies & Distribution